Alteri, Claudia
Scutari, Rossana
Bertoli, Ada
Armenia, Daniele
Gori, Caterina
Fabbri, Gabriele
Mastroianni, Claudio Maria
Cerva, Carlotta
Cristaudo, Antonio
Vicenti, Ilaria
Bruzzone, Bianca
Zazzi, Maurizio
Andreoni, Massimo
Antinori, Andrea
Svicher, Valentina
Ceccherini-Silberstein, Francesca
Perno, Carlo Federico
Santoro, Maria Mercedes
Funding for this research was provided by:
CHAIN (223131)
Italian Ministry of Health (Project n. 2)
Article History
Received: 22 November 2018
Accepted: 11 February 2019
First Online: 22 February 2019
Compliance with ethical standards
:
: The authors have no competing interests that might be perceived to influence the results and/or discussion reported in this paper. However, Francesca Ceccherini-Silberstein reports personal fees from Gilead Sciences, Bristol-Myers Squibb, Abbvie, Roche Diagnostics, Janssen-Cilag, Abbott Molecular, ViiV Healthcare; grants and personal fees from Merck Sharp & Dohme; grants from Italian Ministry of Education, University and Research (MIUR). Carlo Federico Perno reports grants from Italian Ministry of Instruction, University and Research (MIUR), and from Aviralia Foundation; personal fees from Gilead Sciences, Abbvie, Roche Diagnostics, Janssen-Cilag, Abbott Molecular, and grants and personal fees from Bristol-Myers Squibb, Merck Sharp & Dohme, and ViiV Healthcare. All other authors have nothing to declare.
: This study was conducted on data collected for clinical purposes. All data used in the study were previously anonymized, according to the requirements set by Italian Data Protection Code (leg. decree 196/2003) and by the General authorizations issued by the Data Protection Authority. Written informed consent for medical procedures/interventions performed for routine treatment purposes was collected for each patient included in the ARCA database or from other clinical centers involved in the study, in accordance with the ethics standards of the committee on human experimentation and the Helsinki Declaration (1983 revision).